Green Cross Health Limited - Annual Shareholders' Meeting

MEETING
Wed, Jun 26 2024 08:30 am

NOTICE OF ANNUAL MEETING

Notice is hereby given that the 2024 Annual Meeting of Shareholders of Green Cross Health Limited (“the Company”) will be held at the Ellerslie Event Centre 80 Ascot Avenue Greenlane Auckland on Thursday, 1st of August 2024 at 2.30 pm.

BUSINESS:

A. Chair’s Address
B. Group Chief Executive Officer’s Address
C. Audited Financial Statements
D. Resolutions

To consider and, if thought fit, to pass the following ordinary resolutions:

1. That Peter Merton be re-elected as a Director of the Company
2. That Ken Orr be re-elected as a Director of the Company
3. To authorise the Directors to fix the remuneration of the Auditor for the ensuing year.

E. To consider any other matters that may be properly brought before the Annual Meeting.

Proxies and voting

Any shareholder who is entitled to attend and vote at the meeting may instead appoint a proxy to attend and vote on their behalf. The Chair of the Company is willing to act as proxy for any shareholder who may wish to appoint him for that purpose. The Chair intends to vote any undirected proxies in favour of the resolutions.

If you wish to appoint a proxy please complete the enclosed proxy form and mail to:

Computershare Investor Services limited
Private Bag 92119
Auckland 1142

Alternatively, you can complete a proxy form online at www.investorvote.co.nz. You will need the Control Number (found on the Proxy Notice), your CSN/security holder number and postcode or country of residence to vote online.

In either case, for your vote to be effective, your proxy must be received no later than 48 hours before the time of holding the meeting.

Note
Biographical information relating to the Directors standing for re-election at the meeting can be found below.

Afternoon tea will be served at the conclusion of the meeting.

For and on behalf of the Board

Kalpana Goundar
Chief Financial Officer/Company Secretary
Dated: 26 June 2024

Biographical information relating to the Directors standing for re-election:

Peter Merton
Non-Executive Director

Peter Merton, an Otago University Pharmacy graduate, has been involved in the pharmaceutical industry in New Zealand and overseas since the early 1980s.

His involvement with the Company goes back to the late 1990s, and he played an active part in the initial industry consolidation when Amcal and Unichem brands merged to form Pharmacybrands Limited, later renamed Green Cross Health Limited.

Following the merger of Life Pharmacy Limited (LPL) with Pharmacybrands Limited in 2009 Peter assumed the role of Chair of the Group, a role he held until December 2019 when he became a Non-Executive Director. He is also a significant shareholder in the company through his interest in Cape Healthcare Limited. Peter has previously held the roles of Chief Executive of the Propharma/Healthcare Logistics businesses and Director of EBOS Group Limited.

Ken Orr
Independent Director

Ken Orr has had over 30 years as a community pharmacist and is currently a partner in a group of pharmacies in Northland and a director of North Haven Hospice. Ken was a former President of the NZ Pharmacy Guild, which represents the business interests of community pharmacies. Ken was a forming director of Manaia PHO and now serves on the Audit, Risk & Finance Committee of Mahitahi Hauora that leads primary health care in Northland.

Ken joined the Board in September 2009 as an alternate Director and was appointed as an Independent Director of the Company in March 2012.


Announcement PDF


Markets News

NZ sharemarket up 0.1% on flat trading day
Markets Market close

NZ sharemarket up 0.1% on flat trading day

The S&P/NZX 50 Index closed at 11,790.92, up 14.18 points or 0.12%.

Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

Advent International eyes NZ deals with Aussie outpost